Head-to-head · WeighScore
Enhance MD vs Pepti
The verdict
Enhance MD takes it — 84.8/100 to 78.8/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Enhance MD | Pepti |
|---|---|---|
| WeighScore | 84.8/100 | 78.8/100 |
| Grade | B | C+ |
| Site position | #5 | #44 |
| Semaglutide | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay | $109 per 28 days (all-in; billing can fall twice in one calendar month) |
| Tirzepatide | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay | $179 per 28 days (all-in; billing can fall twice in one calendar month) |
| Coverage | Not publicly listed | All 50 states plus Washington, D.C. |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #5 · B
Strengths
- Transparent tiered pricing across sema, tirz, microdose, and combo
- Dose-flat — the price does not step up as you titrate
- Six-month lab testing plus provider-led care
- NAD+ longevity adjacency available
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- No oral or sublingual route
- States served are not published
- Higher entry price than the cheapest compounded programs
Site position #44 · C+
Strengths
- The figure is stated as the full price with no membership fee, free shipping included, on the product page itself
- Names a medical director by name and board certification, and a second named provider
- Baseline labs are described as included when a clinician requires them, with deeper panels priced openly at $149 and a $129 monthly bloodwork plan
- Coverage is all 50 states and the District of Columbia, stated without a hedge
- Roughly forty prescription peptide products are priced alongside the GLP-1 lines
Where it loses points
- The site prints $79 on its own semaglutide cost page and $109 on the same page, and $149 against $179 for tirzepatide; the figures that transact are $109 and $179
- The product pages label the figure an all-in monthly price while the billing terms set the cycle at 28 days and warn it can bill twice in one calendar month
- An “FDA cleared” badge sits in the homepage trust cluster while the product pages state that compounded medication is neither FDA-approved nor FDA-cleared
- “Our pharmacy partners” names exactly one, Olympia, with no legal entity or address, while the same page says the filling pharmacy varies by patient
- Payment is taken before a physician reviews the intake, and the refund is the remedy
- Labs are conditional rather than included, despite plan copy that reads as though they are standard
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.